Metformin has been shown to directly induce antitumor effects by inhibiting the PI3K-Akt/mTOR and Ras-MAPK signaling pathways critical for cancer progression and indirectly by systemically reducing glucose and insulin metabolism to attenuate cancer cell growth (43, 44). This evidence concerns the gene MTOR and cancer.